Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

ISTO Technologies Initiates Phase II Trial of NuQu®: Novel Cell-based Therapy for the Treatment of Painful Spinal Discs 



October 22, 2012 - (ISTO) - " ISTO Technologies, Inc. announced today that it is initiating a Phase II trial to further evaluate the efficacy and safety of its NuQu® cell-based therapy for the treatment of pain and disability associated with degenerated spinal discs."  Read Full Article


Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: